Correlation Between Cue Biopharma and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and X4 Pharmaceuticals, you can compare the effects of market volatilities on Cue Biopharma and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and X4 Pharmaceuticals.
Diversification Opportunities for Cue Biopharma and X4 Pharmaceuticals
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cue and XFOR is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cue Biopharma and X4 Pharmaceuticals
Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the X4 Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Cue Biopharma is 2.2 times less risky than X4 Pharmaceuticals. The stock trades about -0.26 of its potential returns per unit of risk. The X4 Pharmaceuticals is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 50.00 in X4 Pharmaceuticals on August 29, 2024 and sell it today you would lose (15.00) from holding X4 Pharmaceuticals or give up 30.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Cue Biopharma |
| X4 Pharmaceuticals |
Cue Biopharma and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and X4 Pharmaceuticals
The main advantage of trading using opposite Cue Biopharma and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
| X4 Pharmaceuticals vs. Eliem Therapeutics | X4 Pharmaceuticals vs. Scpharmaceuticals | X4 Pharmaceuticals vs. Milestone Pharmaceuticals | X4 Pharmaceuticals vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |